AI-powered Strategy
Choose A Path
See The Rationale
Use FDA precedent, ClinicalTrials.gov and your programme data to shape study designs, endpoints and development strategy. Review the rationale, risks and trade-offs with your experts.
How It Works
TRIBAL BIOPre-IND Package Strategy
Example ProgrammeReview Strategy
Pathway, study design and endpoints, with the evidence behind each choice.
Current Strategy
Pre-IND Briefing Package- Indication & Population
A rare neurological disorder, with an initial study in adolescents and adults able to take an oral capsule.
Programme Facts: Target Population
The programme overview defines the initial indication, age group and formulation requirements.
- Regulatory Pathway
Proposed 505(b)(2) pathway, drawing on published evidence. Discuss the evidence bridge and development plan at a Pre-IND meeting.
Regulatory Strategy: Pathway Rationale
The strategy identifies reliance on published literature and the need to establish its relevance to the proposed product.
- Study Design
A randomised, double-blind, placebo-controlled study, with a prospective baseline and an open-label extension.
Study Protocol: Overall Design
The protocol describes a parallel-group design, followed by longer-term safety and tolerability follow-up.
- Primary Endpoint
Change from baseline in attack frequency, supported by safety and tolerability assessments.
Study Protocol: Primary Endpoint
The proposed endpoint measures changes in attack frequency using prospectively recorded diary data.
Compare An Option
Current Strategy
Start with a defined adolescent and adult population.
Fits the proposed capsule and initial study plan.Option To Explore
Consider a broader population at a later milestone.
Review the additional formulation, dosing and evidence requirements with the team.Open a source note or compare an option to explore the example.
How It Works
Make The Next Decision With Context
Connect the evidence, compare the options and refine the recommendations with your experts
- 01
Connect The Evidence
Bring programme data together with relevant clinical trials, FDA guidance and prior approvals.
- 02
Compare Study Options
Explore study designs and endpoints with the supporting precedent, rationale, risks and trade-offs in view.
- 03
Refine With Your Experts
Review the recommendations with your team, challenge the assumptions and agree the strategy before drafting.
